Wave Life Sciences Ltd Expected To Post A Loss Of 21 Cents A Share: Earnings Preview

Wave Life Sciences

06/08/2024 15:22

* WAVE Life Sciences Ltd  WVE.OQ   WVE.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 8
for the period ending June 30 2024
    * The  Singapore-based   company is expected to report a
10.1% increase in revenue to $24.335 million from $22.11 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for WAVE Life Sciences Ltd
is for
a loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for WAVE Life
Sciences Ltd is $15.00​, above​ its last closing price of $5.89.
​​​

This summary was machine generated August 6 at 14:22 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)